Copyright © 2000 by the BMJ Publishing Group Ltd.
Inhaler devices for asthma
Relevant BNF section: 3.1-3.3
Inhalation therapy is now the mainstay of treatment for asthma but for many patients such treatment is still not optimal. The delivered dose can vary widely between different delivery systems, and between patients, depending on how well they use a particular device. Many new inhaler devices are now available, and their competing promotional claims can confuse both prescribers and patients. In this article we review the devices marketed and discuss how to select the best one for a particular patient.
This article has been cited by other articles:
![]() |
N. J. Roland, R. K. Bhalla, and J. Earis The Local Side Effects of Inhaled Corticosteroids: Current Understanding and Review of the Literature Chest, July 1, 2004; 126(1): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Child, S Davies, S Clayton, A A Fryer, and W Lenney Inhaler devices for asthma: do we follow the guidelines? Arch. Dis. Child., March 1, 2002; 86(3): 176 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Wright, D Brocklebank, and F Ram Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD) Qual. Saf. Health Care, January 12, 2002; 11(4): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. BUCHDAHL, S. WARD, and A. SUMMERFIELD Pseudomonas infection in CF (cystic fibrosis). Thorax, December 1, 2000; 55(12): 1070 - 1071. [Full Text] |
||||




